Personalized Breast Cancer Treatment and Tumor Genomics (BST) (No CME)
This session has been identified and designated as Credit to Meet ACS Accreditation/Verification Requirements for Breast.
Session Description
There is a wide array of treatment options for breast cancer but not all women benefit from each one. Genomic testing of specific tumor types has become of great interest in the evaluation of breast cancer. Assessment of the particular genetic alterations present in an individual’s tumor may provide information in regards to diagnosis, prognosis, and targeted treatment beyond the standard clinicopathological factors. Many gene-based assays are available, and they differ in regards to the intended patient populations, sample requirements, genes evaluated, results, and validation. This panel will discuss the different types of multi-gene signature tests that are available, clinical utility, and appropriate patient selection.
Course Outline
Personalized Breast Cancer Treatment and Tumor Genomics
- Susan K. Boolbol, MD, FACS, New York, NY
- Lee G. Wilke, MD, FACS, Madison, WI
Target Audience
- Practicing surgeons
- Residents
Learning Objectives
- Apply new knowledge and ideas to improve their surgical practice
- Adapt concepts and quality measures in support of research advancements
- Enhance the quality of patient care
Contact
- For questions about the course content, please contact elearning@facs.org.
- If you have any technical questions, contact learning@facs.org.
Disclosure Information
In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any commercial interest. For additional information, please visit the ACCME website: http://www.accme.org/requirements/accreditation-requirements-cme-providers/policies-and-definitions/financial-relationships-and-conflicts-interest
The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during a activity, please report it on the evaluation.
(Download the full list of disclosures.)
Faculty and Disclosures
Elizabeth Mittendorf, MD, FACS - Merck, Astra Zeneca, Genentech, Peregrine Pharmaceuticals, Sellas LifeSciences: honoraria
Jennifer Gass, MD, FACS - Invuity, Inc: honoraria
Brigid Killelea, MD, MPH, FACS - No Disclosures
Program Committee and Disclosures
CHAIR: Henri R. Ford, MD, MHA, FACS, FAAP, FRCSEng(Hon), Miami, FL - No Disclosures
VICE-CHAIR: David T. Cooke, MD, FACS, Sacramento, CA - No Disclosures
Members
David C. Borgstrom, MD, FACS, Morgantown, WV - No Disclosures
Daniel L. Dent, MD, FACS, San Antonio, TX - No Disclosures
Roger R. Dmochowski, MD, FACS, Nashville, TN - Allergen: Honoraria: Consultant
Audra A. Duncan, MD, FACS, London, ON - No Disclosures
Mariam F. Eskander, MD, Boston, MA - No Disclosures
Paula Ferrada, MD, FACS, Richmond, VA - No Disclosures
Neil H. Hyman, MD, FACS, Chicago, IL - No Disclosures
Martin S. Karpeh, Jr., MD, FACS, New York, NY - No Disclosures
Dennis H. Kraus, MD, FACS, New York, NY - No Disclosures
Kenneth W. Sharp, MD, FACS, Nashville, TN - No Disclosures
David A. Spain, MD, FACS, Stanford, CA - No Disclosures
Ex- Officios
Mary T. Hawn, MD, FACS, Stanford, CA - No Disclosures
Daniel M. Herron, MD, FACS, FASBMS, New York, NY - No Disclosures
Consultants
Barbara Lee Bass, MD, FACS, FRCS(Hon), Houston, TX - No Disclosures
Quan-Yang Duh, MD, FACS, San Francisco, CA - No Disclosures
B. J. Hancock, MD, FACS, FRCSC, Winnipeg, MB - No Disclosures
Ronald V. Maier, MD, FACS, FRCSEd(Hon), Seattle, WA - No Disclosures
Valerie W. Rusch, MD, FACS, New York, NY - No Disclosures
A Certificate of Completion will be awarded.
This educational activity is not eligible for CME or CE credits.
Available Credit
- 0.00 AMA PRA Category 1 Credit™
- 0.00 Certificate of Completion
- 0.00 Self Assessment Credit